Compare CVS Health Corp (CVS) vs PepsiCo, Inc. (PEP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs PepsiCo, Inc. — how do they compare? CVS Health Corp trades at $106.18 (market cap $135.48B), while PepsiCo, Inc. trades at $136.06 (market cap $184.87B). The key difference: PepsiCo, Inc. is the larger of the two by market cap, and PepsiCo, Inc. pays the higher dividend (4.37%). Which is the better fit depends on your goals.
| CVS | PEP | |
|---|---|---|
Market Cap | $135.48B | $184.87B |
Sector | Health | Consumer Staples |
52-Week High | $106.18 | $170.44 |
52-Week Low | $58.75 | $133.81 |
Enterprise Value | $202.02B | $227.37B |
Dividend Yield | 2.51% | 4.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
PepsiCo (PEP) trades at $135.11, down 2.44% over the past day, with a bearish technical outlook. The stock shows strong profitability with a 10.78% net income margin and 51.59% ROE, though revenue growth remains modest. Recent earnings have consistently beaten estimates, and the company maintains a solid dividend. However, price pressures on snacks and high debt levels pose challenges. Analyst consensus is a 'Hold' with a $159.27 price target, indicating potential upside from current levels.
The outlook for PEP is mixed: fundamentals are robust with earnings beats and high returns, but technicals and sentiment are cautious. Investment opportunity lies in valuation discount to analyst targets and dividend yield, while risks include consumer pushback on pricing, competitive pressures, and leverage. Near-term performance hinges on Q3 2026 earnings and North American segment recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →
